Our guidelines are developed by independent committees, including healthcare professionals, service users, and lay members. They cover a wide range of topics, from preventing and managing specific conditions to improving health and promoting social care.
About our guidance
We use the best available evidence to develop guidance to improve health and social care.
Our guidance takes many forms: NICE guidelines (clinical, social care, public health, medicines practice), technology appraisals, interventional procedures, medical technologies, diagnostics and highly specialised technologies.
NICE guidance
Find out more about the different types of NICE guidance.
This guidance assesses the clinical and cost effectiveness of health technologies, such as new medicines, procedures, devices and diagnostic agents.
This guidance evaluates new, innovative medical devices and diagnostics. It looks at medical technologies that deliver treatment, give greater independence to patients, and detect or monitor medical conditions.
This guidance contains recommendations on the use of new and existing highly specialised medicines and treatments.
This guidance evaluates new, innovative diagnostic technologies. It includes all types of measurements and tests that are used to evaluate a patient's condition.
This guidance recommends whether interventional procedures - such as laser treatments for eye problems or deep brain stimulation for chronic pain - are effective and safe enough for use in the NHS.
Summaries of the best available evidence to inform local NHS planning and decision making, for selected new medicines, off-label use of licensed medicines and unlicensed medicines.
We’re bringing our guidance together by topic, so that it’s all in one place, clearer to understand and easier to use.
We make 4 types of recommendation which apply across all our medicines and health tech guidance products.
We use a framework for modular updates to keep our methods flexible and responsive to changes in health and care.
Prioritising our guidance topics
It's important that we prioritise those areas of guidance development and delivery that will have the greatest impact on the health and care system. To do this we're developing a new centralised approach.